A Gary Lyons
Affiliations
- Director at Neurocrine Biosciences Inc (NBIX), 2025-05-22
- at Travere Therapeutics Inc. (TVTX), 2025-05-16
- at Rigel Pharmaceuticals Inc (RIGL), 2023-07-12
- Director at Eledon Pharmaceuticals Inc. (ELDN), 2023-05-02
- Director at Brickell Biotech Inc. (BBI), 2022-05-17
- Director at Cytori Therapeutics Inc. (CTYX), 2018-02-09
- Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
- Director at Neurogesx Inc (NGSX), 2012-06-12
- Director at Poniard Pharmaceuticals Inc. (PARD), 2011-07-12
- Director at Facet Biotech Corp (FACT), 2010-04-23
Insider Trading: Purchases See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
VICL | $4.39 | 7,078 | $31,088.70 | 14,906 | 2016-06-03 | Filing |
VICL | $0.01 | 5,953 | $59.53 | 63,281 | 2013-05-23 | Filing |
VICL | $0.01 | 7,328 | $73.28 | 57,328 | 2012-05-24 | Filing |
VICL | $0.01 | 18,750 | $187.50 | 50,000 | 2011-05-26 | Filing |
VICL | $0.01 | 18,750 | $187.50 | 31,250 | 2010-05-25 | Filing |
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
TVTX | $15.15 | 18,821 | $285,226.61 | 51,000 | 2024-10-04 | Filing |
TVTX | $14.35 | 21,179 | $303,874.17 | 69,821 | 2024-10-04 | Filing |
NBIX | $150.43 | 11,570 | $1,740,449.65 | 119,047 | 2024-08-13 | Filing |
NBIX | $150.03 | 930 | $139,530.23 | 119,047 | 2024-07-16 | Filing |
NBIX | $135.63 | 12,500 | $1,695,370.00 | 116,947 | 2024-05-14 | Filing |